JPND research

JPND research

The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase coordinated investment between participating countries in research aimed at finding causes, developing cures, and identifying appropriate ways to care for those with neurodegenerative diseases.

Read more


Alzheimer's Disease International

Alzheimer's Disease International

ADI is a global umbrella organisation, with members in all parts of the world. From Argentina to Singapore, the USA to South Africa, we involve professionals, but also family members, carers and people with dementia.

Read more


Alzheimer's Disease Health Center

Alzheimer's Disease Health Center

Symptoms of Alzheimer's, including early-onset Alzheimer's, include problems with memory, judgment, and thinking. Memory loss and dementia will progress as the stages of Alzheimer's advance. Symptoms can be treated with medication, but there is no cure

Read more


Parkinson's Disease Health Center

Parkinson's Disease Health Center

Parkinson’s disease affects the nerve cells in the brain that produce dopamine. Parkinson’s disease symptoms include muscle rigidity, tremors, and changes in speech and gait. After diagnosis, treatments can help relieve symptoms, but there is no cure.

Read more


Alzheimer's Association 2017 Alzheimer's Disease Facts and Figures

Alzheimer's Association 2017 Alzheimer's Disease Facts and Figures

More than 5 million Americans are living with Alzheimer's disease. Share the facts and join the fight at alz.org/facts.

Read more


Prevalence and Cause of Parkinson's Disease - Movement Disorder Center of the Colorado Neurological Institute

Prevalence and Cause of Parkinson's Disease - Movement Disorder Center of the Colorado Neurological Institute

In this video, episode 2 of the series, we discuss the prevalence of Parkinson's disease throughout the world as well as various causes of the disease, such as environment and genetics. This unique series is designed to educate newly diagnosed patients and the general public about Parkinson's disease.

Read more


Alz.org - Research Center

Alz.org - Research Center

Alzheimer's Association Pioneer Award for Alzheimer's Research recipient Dennis Selkoe, M.D., explores one of the potential causes of cognitive decline in Alzheimer's disease — the beta-amyloid protein — and progress in developing treatments to target beta-amyloid.

Read more


National Parkinson Foundation

National Parkinson Foundation

There is no “one way” to diagnose Parkinson’s disease (PD). However, there are various symptoms and diagnostic tests used in combination. One of the most important things to remember about diagnosing PD is that there must be two of the four main symptoms present over a period of time for a neurologist to consider a PD diagnosis.

Read more


Medscape - Parkinson Disease Treatment & Management

Medscape - Parkinson Disease Treatment & Management

The goal of medical management of Parkinson disease is to provide control of signs and symptoms for as long as possible while minimizing adverse effects. Studies demonstrate that a patient's quality of life deteriorates quickly if treatment is not instituted at or shortly after diagnosis.

Read more


NIH - MedlinePlus

NIH - MedlinePlus

The clearest risk factor is age. In addition, researchers have identified a number of genes that cause or contribute to Parkinson's disease (PD), as well as potential environmental risk factors. A primary piece of evidence that environmental factors play a role is that the relative risk of PD is higher in industrialized countries.

Read more

THIS WEBSITE STORES AND GAIN ACCESS TO INFORMATION ALREADY STORED IN USER’S DEVICE BY THE USAGE OF COOKIES. CONSENT OR LACK OF CONSENT FOR THE USAGE OF COOKIES MAY BY EXPRESSED BY A BROWSER CONFIGURATION